Infervision Shines at CMEF with AI-Powered Innovations, Unveils Comprehensive Clinical Solutions

On the 17th, the 87th China International Medical Equipment Fair (CMEF) concluded successfully in Shanghai. Nearly 5,000 companies showcased tens of thousands of cutting-edge products, and hundreds of thousands of industry professionals gathered for this spring event to welcome the golden decade of development for China's medical device market.

This year, Infervision made its official debut at the CMEF Expo, unveiling a range of innovative AI products and solutions that span multiple major disease areas—from imaging to full-process clinical management. The showcase attracted significant attention from medical professionals both in China and abroad, establishing Infervision as the standout “blue ocean” highlight of the event.

Infervision’s Founder and Chairman, Chen Kuan; Co-founder and General Manager, Wang Shaokang; and President, Xu Weiying, personally presided over the booth, engaging with Infervision’s friends new and old, partners, industry leaders, and media representatives to share insights and exchange views on the value and prospects of AI in healthcare.

The Convergence of Technology and Medicine: Deepening Integration of AI in Healthcare, with AI Becoming a Core Driver of Smart Healthcare Development. As a Leading Enterprise in Medical AI, Infervision Persists in Original Innovation and Unveils Four Major Solutions On-Site.

Wang Shaokang, Co-founder and General Manager of Infervision, stated that during the early stages of the company’s founding, they collaborated with physicians to explore the feasibility of AI technologies and products. The team was stationed in hospitals, working alongside doctors to learn, conduct research, gather clinical needs, and address the most pressing real-world clinical challenges. Currently, AI is widely applied in radiology departments. We also observe significant opportunities for innovation in clinical specialties, medical education and training, and health informatics, making the future highly promising.

■ Infervision AI-4D Platform

Accelerating the Development of Smart Imaging Centers

■ Hospital-Wide Solution for Comprehensive Management of Pulmonary Nodules

Establishing Industry Benchmarks

■ Infermedica AI Interactive Teaching Platform

Making Smart Education Within Reach

■ Inferential AI + Innovative Applications

Leading the Industry Toward Limitless Expansion

Infervision has officially launched its AI-4D platform, which encompasses a suite of reconstruction and structured reporting solutions. Leveraging deep learning and image recognition technologies, the platform automatically reconstructs two-dimensional medical images into three-dimensional volumetric representations.Facilitates rapid and precise access to rich, multi-dimensional lesion and anatomical information for physicians, supporting a return to precision diagnosis and enhancing the value of radiology departments.

The AI-4D platform comprehensively covers various clinical reconstruction scenarios, including target reconstruction of pulmonary nodules, as well as reconstructions of the pulmonary vasculature, cardiovascular system, cerebrovascular system, hepatobiliary system, and urinary system. It automatically fuses multi-phase reconstruction results, performs reconstructions efficiently and automatically, and automatically archives data to generate structured reports.

Comprehensive Hospital-Wide Solution for Full-Cycle Management of Pulmonary NodulesBy providing end-to-end coverage across screening, diagnosis, treatment, follow-up, and scientific research, and leveraging differentiated advantages such as the seamless integration of AI into clinical pathways across multiple scenarios, this solution has become an industry benchmark in the global high-throughput thoracic and pulmonary market. The solution seamlessly interfaces with hospital HIS and PACS systems, while aggregating data from various stages of the diagnostic and therapeutic workflow to build a specialized disease database, thereby empowering scientific research initiatives across clinical departments. In-hospital application spans multiple departments, including Radiology, Health Examination Center, Respiratory Medicine, Oncology, Thoracic Surgery, and Interventional Departments.In particular, AI solutions related to precision diagnosis and treatment have received high recognition and acclaim from numerous authoritative experts and healthcare professionals both in China and abroad.

"The Infermed AI Interactive Teaching Platform is the company's latest professional teaching system dedicated to medical AI."“AI + Medical Education” Will Be the Direction of the Times: Infervision Proposes to Establish a National Artificial Intelligence Medical Imaging Training Center to Empower the Cultivation of Radiology Talent with AI, faithfully replicating clinical teaching scenarios to shorten the learning curve for trainees; by constructing CDSS clinical pathways and knowledge bases, it enables radiologists to perform independent queries, leverages AI to enhance image interpretation capabilities, assists in clinical diagnosis and treatment, and utilizes AI to establish a training evaluation system. It provides knowledge bases for medical schools and postgraduate education markets, thereby promoting the development of intelligent education and training platforms.

Infervision’s 12 AI-powered, full-scenario solutions encompass three major directions: high-throughput clinical applications in the thoracic and pulmonary fields, real-world hospital-based implementations, and intelligent cloud platforms.Intelligent imaging empowers the entire hospital, covering multiple disease areas such as cancer, infectious diseases, cardiovascular diseases, cerebrovascular diseases, and trauma. It continuously deepens clinical expansion and develops end-to-end smart solutions for “screening, diagnosis, treatment, management, and research” along the entire patient care journey.

Infervision continuously innovates in scenario-based applications. Among these, Infervision AI-4D empowers hospital smart printing centers by providing personalized, precise, and minimally invasive customized services for clinical surgeries, helping hospitals establish regional benchmarks.

It is envisioned that an AI-powered intelligent imaging diagnostic unit for stroke will be deployed within 5G-enabled mobile stroke units, launching a comprehensive solution integrating 5G, AI, and mobile stroke care to achieve “hospital admission upon boarding” and improve stroke treatment outcomes. This project has also been selected as a pilot initiative for 5G+ medical health applications by the Ministry of Industry and Information Technology and the National Health Commission.

TuiXiang has consistently led industry development in AI applications, continuously expanding its application trials, and will launch an increasing number of scenario-based applications in the future.

Infervision’s debut at the CMEF expo was a resounding success. Its meticulously curated exhibits and engaging activities attracted countless visitors, with steady crowds flocking to its futuristic, tech-infused booth over the four-day event. It emerged as the most popular international AI exhibit, drawing numerous domestic and foreign professionals for visits and exchanges. Beyond touring the exhibit and networking, many attendees also expressed their high expectations for Infervision and the future of AI in healthcare.

Meanwhile, Infervision’s booth stood out as the most “blue-ocean” showcase, brimming with cutting-edge technology and innovative solutions, and attracting numerous media influencers to explore the exhibit.

Beyond the on-site experience, Infervision also enabled online audiences to attend the exhibition via live streaming, offering an immersive glimpse into the impressive capabilities of its full suite of AI-powered medical products.

The deep integration of AI and digital technologies with medical equipment management and services is a major application scenario driven by the “Healthcare + Internet” model.

During this year’s CMEF, GE HealthCare launched and upgraded its service offerings and solutions tailored to the diverse needs of healthcare institutions, empowering hospitals to enhance equipment management and clinical care capabilities through the integration of digital and physical technologies. As a key partner in GE HealthCare’s AI-powered intelligent services, Chen Kuan, Founder and Chairman of Infervision, was invited to attend the launch ceremony for GE HealthCare’s “Smart Magic Box Family 2.0,” pioneering a new future of smart healthcare driven by digital technology.

Chen Kuan, Founder and Chairman of Infervision (9th from left), attends the launch ceremony of GE Healthcare’s “IntelliBox Family 2.0”

Reflecting on CMEF, Chen Kuan, Founder and Chairman of Infervision, stated:

“As a pioneer among AI-driven healthcare technology companies, Infervision has continuously evolved from intelligent imaging screening to clinical imaging applications, advancing along its ‘horizontal and vertical’ strategic framework for AI in healthcare: horizontally covering major disease areas, and vertically addressing the full lifecycle of each disease.”

“In addition to empowering physicians at top-tier hospitals to achieve clinical excellence and spearhead scientific research, artificial intelligence (AI) must, more importantly, be deployed in primary healthcare institutions, enabling the general public to access high-quality medical services within their own communities. Furthermore, while rooted in China, we will promote advanced technologies worldwide to serve patients globally. We look forward to collaborating with leading global enterprises, renowned experts, and industry organizations to jointly advance the application and development of AI in the healthcare sector.”